Arlington Trust’s Edwards Lifesciences EW Stock Holding History

Arlington Trust’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$145K	Buy	1,679 +29	+2%	+$2.58K	0.01%	184
2026 Q2	$149K	Hold	1,650	–	–	0.01%	149
2026 Q1	$132K	Buy	1,650 +15	+0.9%	+$1.24K	0.01%	133
2025 Q4	$139K	Sell	1,635 -10,595	-87%	-$869K	0.01%	118
2025 Q3	$951K	Hold	12,230	–	–	0.17%	69
2025 Q2	$957K	Buy	12,230 +1,138	+10%	+$84.9K	0.19%	68
2025 Q1	$804K	Buy	11,092 +135	+1%	+$9.7K	0.17%	74
2024 Q4	$811K	Buy	10,957 +120	+1%	+$8.4K	0.17%	71
2024 Q3	$715K	Sell	10,837 -613	-5%	-$44.5K	0.16%	78
2024 Q2	$1.06M	Sell	11,450 -832	-7%	-$73.7K	0.25%	55
2024 Q1	$1.17M	Sell	12,282 -24	-0.2%	-$2.02K	0.3%	50
2023 Q4	$938K	Buy	12,306 +12,069	+5,092%	+$840K	0.26%	57
2023 Q3	$16.4K	Buy	+237	New	+$19K	0.01%	198

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Arlington Trust's EW Position: Q3 2026 in Review

Arlington Trust increased its Edwards Lifesciences (EW) stake by 1.8% in Q3 2026, buying an estimated $2.58K and bringing the position to 1,679 shares worth $145K. The position accounts for 0.01% of the portfolio, ranked #184.

Arlington Trust first reported a position in EW in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.17M in Q1 2024. 326 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Arlington Trust held 1,679 shares of Edwards Lifesciences worth $145K as of Q3 2026.
Arlington Trust bought 29 Edwards Lifesciences shares in Q3 2026, an estimated $2.58K.
Edwards Lifesciences made up 0.01% of Arlington Trust's portfolio in Q3 2026, its #184 holding.
Arlington Trust first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 13 quarters since.
Arlington Trust's Edwards Lifesciences position peaked at $1.17M in Q1 2024.
326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Arlington Trust's 13F filing for Q3 2026, filed 20 Oct 2026.